New Weight Loss Pill Cuts Body Weight By 20%
Breakthrough obesity drug Orforglipron shows unprecedented results in clinical trials, reducing body weight by a fifth and offering new hope for millions struggling with weight management in the UK.
Category : Search result: pharmaceutical manufacturing
NHS Must Reverse Medicines Investment Decline - Minister
Former chief scientific adviser Sir Patrick Vallance warns that dwindling investment in medical research and innovation threatens the future of the NHS and patient care. Discover the urgent call for action.
AstraZeneca shifts cancer drug production from UK to Ireland
Pharmaceutical giant Merck to manufacture flagship cancer drug Lynparza at new €1 billion Irish facility, dealing significant blow to UK's life sciences sector and raising fresh post-Brexit trade concerns.
Trump Threatens NHS Drug Pricing: UK Faces US Medicine Costs
Exclusive analysis reveals how a potential Trump presidency could jeopardise Britain's NHS medicine pricing, forcing UK patients to pay US-style pharmaceutical costs.
Big Pharma's Billion-Pound Bet on Post-Trump UK
Major pharmaceutical giants AstraZeneca, MSD (Merck), and Eli Lilly announce massive new investments in UK research and manufacturing, signalling a major vote of confidence in the British life sciences sector following the US election result.
AstraZeneca Pauses £500m Cambridge HQ Investment
Pharmaceutical giant AstraZeneca has paused plans for its new £500 million global headquarters in Cambridge, citing an 'unfavourable' UK economic climate and sending shockwaves through the business community.
Common Meds Linked to Youth Suicide Surge, Study Finds
Groundbreaking research uncovers a disturbing correlation between widely prescribed drugs, including beta-blockers and anti-anxiety medications, and a sharp increase in suicide risks and depression in children and young adults. Experts are calling for urg
AstraZeneca Pauses £200m Cambridge Research Investment
Pharmaceutical giant AstraZeneca pauses its major £200m Cambridge research centre expansion, citing global strategic review and UK economic uncertainty in post-Brexit landscape.
Cyber Attack Halts Jaguar Land Rover Production
UK manufacturing giant Jaguar Land Rover is grappling with severe production delays after a sophisticated cyber attack targeted its internal servers, causing significant disruption to its UK operations.
Sanofi CEO: UK is 'terrible place' for medicines
Sanofi executive warns of UK's worsening medicines access crisis, citing post-Brexit regulations, NICE hurdles, and a pricing system that deters investment and innovation.
UK Economy Stagnates with 0.0% GDP Growth, FTSE 100 Falls
The UK economy showed zero growth in April 2024, causing the FTSE 100 to fall sharply. Construction and manufacturing output dropped significantly, raising concerns about the nation's economic health.
MSD to create 125+ new R&D jobs in London expansion
Pharmaceutical giant MSD, known as Merck in the US, is significantly expanding its UK presence with a new state-of-the-art research hub in London, generating over 125 new high-skilled jobs and reinforcing the city's status as a global life sciences leader
Faulty NHS GPS Trackers Endanger Vulnerable Patients
Exclusive investigation reveals critical safety failure in GPS monitoring devices used by the NHS and care providers, leaving patients with conditions like dementia at severe risk.
Trump pressured FDA to fast-track Covid vaccine before election
Exclusive report reveals Donald Trump pressured US health officials to accelerate vaccine approval for political gain ahead of the 2020 election, according to congressional investigation.
Mounjaro KwikPens launch without price reduction
Exclusive: Diabetes and weight loss patients face financial strain as Eli Lilly's new Mounjaro KwikPens hit the market without the anticipated price reduction, maintaining a premium cost for the identical medication.
Novo Nordisk's £90m UK Expansion for Ozempic Production
Danish pharmaceutical giant Novo Nordisk announces major £90 million expansion at its Gatwick facility to meet soaring global demand for its blockbuster diabetes and weight-loss drugs, Ozempic and Wegovy, creating new high-skilled jobs.
Hyundai Alabama Factory Raid: 150 Workers Arrested in ICE Operation
US immigration agents have detained 150 workers at a Hyundai-owned factory in Alabama. The raid targeted employees suspected of using fraudulent visas and identity documents, sparking a major legal and corporate scandal.
Congress Grills Pharma Over Child Vaccine-Linked Illnesses
A tense US Congressional hearing investigates a surge in severe neurological illnesses in children following vaccination, as lawmakers demand answers from pharmaceutical executives.
Wegovy Jab Sends Novo Nordisk Shares Soaring Past £400bn
Danish pharmaceutical giant Novo Nordisk's market value skyrockets past £400bn, briefly eclipsing the entire Danish economy, on the back of soaring demand for its blockbuster weight-loss drug, Wegovy.
Germany seizes illegal Wegovy shipment in Frankfurt
German authorities have confiscated thousands of doses of the in-demand weight-loss medication Wegovy from a Frankfurt wholesaler, citing illegal parallel imports from outside the EU and improper storage conditions.
Trump Claims Apple AirPods Are Made in Italy, Not China
Former US President Donald Trump alleges Apple's AirPods are manufactured in Italy, not China, igniting a fresh debate on global trade and tech supply chains.
Trump Demands Probe After ICE Raids Hyundai Plant
Ex-President Trump calls for a federal investigation after ICE raids a Hyundai-owned plant in Alabama, alleging underage migrant workers were employed in 'appalling' conditions.
Teen dies after starting new asthma medication
A 13-year-old girl from Northern Ireland tragically passed away just days after being prescribed a new asthma medication. Her devastated family is now demanding answers from health authorities.
New heart drug fails to outperform aspirin in major trial
Groundbreaking medical research reveals a new anti-inflammatory drug shows no significant advantage over traditional aspirin for heart attack prevention in most patients, challenging pharmaceutical expectations.
JLR Cyber Attack Causes Major Production Delays Until October
Jaguar Land Rover faces extended factory shutdowns and delivery delays until October following a severe cyber attack, as the UK automotive giant battles to secure its systems and protect customer data.
US Authorities Raid Hyundai Plant in Immigration Crackdown
US federal agents have executed a dramatic raid on Hyundai's Alabama factory, arresting dozens of undocumented minors in a major escalation of workplace immigration enforcement.
UK Aims to Be Defence 'Workshop of the World'
Defence Secretary John Healey announces a major strategic shift to revitalise UK defence manufacturing, create jobs, and strengthen national resilience against global threats.
Hyundai Georgia Plant Sparks Diplomatic Row with South Korea
A major diplomatic rift has erupted between South Korea and Georgia after a Hyundai supplier was accused of using child labour. Seoul has summoned the US ambassador in a dramatic escalation.
Hyundai defies Trump, keeps Georgia EV plant on track
South Korean automotive giant Hyundai Motor confirms it will continue operations at its massive electric vehicle plant in Georgia, despite former President Donald Trump's threats against automakers employing union labour.
West Coast States Form Historic Vaccine Safety Alliance
In a landmark move for public health, California, Oregon, and Washington announce a unified 'West Coast Pact' to independently review COVID-19 vaccines, prioritising safety and science over political pressure.
Page 1 of 4